As almost half of the 57 colorectal cancer patients enrolled in the present study exhibited BNIP3 promoter methylation, we speculate that inactivation of the BNIP3 gene may occur during the early stage of colon cancer development. The gene discussed is BNIP3; the disease is malignant colon neoplasm.